IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Foresite Capital Management IV, LLC

Q4 2019 Holdings

Filed 2020-02-14 | 14 holdings | $51.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Cytokinetics Incorporated(CYTK)COM NEW23282W605$25.5M2,398,97049.3%
Arbutus BioPharma Corp.(ABUS)COM03879J100$10.3M3,705,12820.0%
Ascendis Pharma A/S(ASND)SPONSORED ADR04351P101$9.6M68,98118.6%
Alector, Inc.(ALEC)COM014442107$6.1M353,46211.8%
Aerie Pharmaceuticals, Inc.(AERIEUR)COM00771V108$36.3K1,501,4000.1%
The Medicines CompanyCOM584688105$34.2K403,2170.1%
Insmed Incorporated(INSM)COM457669307$34.1K1,429,5180.1%
Fulcrum Therapeutics, Inc.(FULC)COM359616109$25.0K1,500,0000.0%
Myokardia, Inc.COM62857M105$19.0K260,3700.0%
Voyager Therapeutics, Inc.(VYGR)COM92915B106$11.6K830,5650.0%
OptiNose, Inc.COM68404V100$8.0K870,7660.0%
Si-Bone, Inc.(SIBN)COM825704109$6.6K308,1830.0%
CymaBay Therapeutics, Inc.(CBAYUSD)COM23257D103$4.5K2,315,0160.0%
Kura Oncology, Inc.(KURA)COM50127T109$93568,0000.0%